NDAORALCAPSULE, DELAYED REL PELLETSPriority Review
Approved
Sep 1989
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
4/8 — Partial
Priority Review
PRILOSEC (omeprazole) by AstraZeneca is proton pump inhibitors [moa]. First approved in 1989.
Drug data last refreshed 2d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PRILOSEC (omeprazole) is a proton pump inhibitor that reduces gastric acid production by blocking H+/K+-ATPase in parietal cells. It is indicated for gastroesophageal reflux disease, peptic ulcer disease, and off-label use across multiple therapeutic areas including oncology and neurology. The drug is an oral delayed-release capsule formulation approved since 1989.
$3MPart D
LOE ApproachingDeclining
LOE approaching signals contraction of brand team and shift toward generic optimization or new indication development to sustain revenue.
Mechanism of Action
Proton Pump Inhibitors
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants
Started Oct 2025
28 enrolled
Healthy Adult Participants
A Study to Learn if Taking BIIB141 (Omaveloxolone) Affects How Omeprazole is Processed in the Body and About BIIB141's Safety in Healthy Adults Aged 18 to 55
Started Sep 2025
22 enrolled
Healthy Volunteer
Effects of Omeprazole Ingestion on Postprandial Amino Acid Concentrations in Response to a Mixed Meal
Started Sep 2025
4 enrolled
Digestive HealthGastrointestinal Health
A Study of Food Effect and Esomeprazole on LY4064809 in Healthy Adult Participants
Started May 2025
36 enrolled
Healthy
Pharmacokinetic Effect of Y-3 on Repaglinide，Warfarin and Omeprazole in Healthy Participants
Started May 2025
24 enrolled
Pharmacokinetic ProfilesY-3 for InjectionDrug-drug Interaction+4 more
Worked on PRILOSEC at AstraZeneca? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.